Thrivent Financial for Lutherans
VBIV

Thrivent Financial for Lutherans’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Thrivent Financial for Lutherans’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10,537
Closed -$983K – 2538
2021
Q1 		$983K Sell
10,537
-6,485
-38% -$658K ﹤0.01% 1882
2020
Q4 		$1.4M Hold
17,022
– – ﹤0.01% 1536
2020
Q3 		$1.46M Buy
17,022
+9,477
+126% +$1.1M ﹤0.01% 1346
2020
Q2 		$701K Buy
+7,545
New +$416K ﹤0.01% 1733

Other funds holding VBIV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Thrivent Financial for Lutherans's VBIV Position: Q2 2021 in Review

Thrivent Financial for Lutherans sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2021, closing a stake of 10,537 shares — an estimated $983K sold.

Thrivent Financial for Lutherans first reported a position in VBIV in Q2 2020 and held it in 4 quarters. The position peaked at $1.46M in Q3 2020. 134 funds tracked by Wall St. Rank hold VBIV as of Q2 2021.

  • Thrivent Financial for Lutherans reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2021 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 10,537 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2021, an estimated $983K.
  • Thrivent Financial for Lutherans first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2020 and held it in 4 quarters.
  • Thrivent Financial for Lutherans's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $1.46M in Q3 2020.
  • 134 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2021.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2021, filed 19 Aug 2021.